These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34238128)

  • 1. A DNA methylation profile of long non-coding RNAs can predict OS in prostate cancer.
    Cheng W; Cao J; Xia Y; Lei X; Wu L; Shi L
    Bioengineered; 2021 Dec; 12(1):3252-3262. PubMed ID: 34238128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
    Gong X; Ning B
    Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of genome-wide DNA methylation patterns in noncoding miRNAs and lncRNAs in uveal melanomas.
    Zheng Z; Xu D; Shi K; Chen M; Lu F
    Aging (Albany NY); 2019 Aug; 11(16):6153-6174. PubMed ID: 31433788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
    Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
    Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer.
    Shao N; Zhu Y; Wan FN; Ye DW
    Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
    Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
    Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
    Zhang P; Tan X; Zhang D; Gong Q; Zhang X
    PLoS One; 2021; 16(5):e0249951. PubMed ID: 33945533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer.
    Li Y; Meng L; Shi T; Ren J; Deng Q
    Cell Biol Int; 2021 Jan; 45(1):117-126. PubMed ID: 32991011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and diagnosis of prostate cancer based on hypergraph regularization sparse least partial squares regression algorithm.
    Huang RH; Ge ZL; Xu G; Zeng QM; Jiang B; Xiao GC; Xia W; Wu YT; Liao YF
    Aging (Albany NY); 2024 May; 16(11):9599-9624. PubMed ID: 38829766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
    Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
    Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
    Liao LE; Hu DD; Zheng Y
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.